Dr. Alan Bonder, MD

Dr. Bonder practices at Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health.

Dr. Bonder's NPI, 1447392006, was assigned on February 12, 2007. Dr. Bonder graduated from Universidad Anahuac School of Medicine in 2004. Dr. Bonder holds Massachusetts license 207R0000X.

Dr. Bonder's primary practice is Beth Israel Deaconess Medical Center, at 330 Brookline Avenue, Boston, MA 02215 in Suffolk County. The practice phone is (617) 667-7000.

Dr. Bonder's primary practice is Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health. Dr. Bonder is also affiliated with The Miriam Hospital. The medical group on file is Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP). Dmand AI also links Dr. Bonder to 3 more hospitals and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bonder practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Bonder's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Bonder is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Bonder's licenses on file in 2 states: Massachusetts and New Hampshire.

Dmand AI lists chronic diabetes, chronic kidney disease, cirrhosis, cirrhosis of the liver, encephalopathy, fatty liver, gastrointestinal infection and liver disease among the conditions Dr. Bonder treats.

CMS data shows 387 Medicare services from Dr. Bonder across 5 procedure codes in 2024, for 247 Medicare patients. Medicare paid $36,248 for them.

CMS counts 247 Medicare patients who saw Dr. Bonder in 2024. The largest group is 65 to 74, with 121 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bonder's median patient age at 63, with 44% women.

In 2024, Dr. Bonder wrote 1,938 Medicare Part D claims for 289 patients. 88% of them were for generic drugs. CMS names the drug for 1,692 of them, across 37 drugs with 11 or more claims each, at $509,804 in total drug cost. In 2023, CMS named 1,774 claims across 40 drugs.

Dr. Bonder accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 21 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Bonder, more than 51% of the clinicians it reports for that procedure.

Dmand AI links 74 papers to Dr. Bonder, published from 2010 to 2025. 2024 was the busiest year, with 10. The most frequent topics are Liver Cirrhosis, Biliary, Liver Transplantation and Liver Cirrhosis. Dr. Bonder has published most often in J Clin Med. Dr. Bonder's most frequent co-authors are Vilas R. Patwardhan, MD, Daniela Nicol Goyes, MD and Hirsh Divyang Trivedi, MD.

CMS Open Payments shows 74 general payments to Dr. Bonder from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 67% of the total. GlaxoSmithKline, LLC. paid the most, $36,109.

Dr. Bonder graduated from Universidad Anahuac School of Medicine in 2004.

Dr. Bonder is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.